Drug Shortage Report for NUCALA

Last updated on 2021-01-21 History
Report ID 130613
Drug Identification Number 02492989
Brand name NUCALA
Common or Proper name Mepolizumab Injection
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) MEPOLIZUMAB
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size PRE-FILLED AUTOINJECTOR x1 / AUTOINJECTEUR PRÉ-REMPLI x1
ATC code R03DX
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-18
Estimated end date 2021-02-01
Actual end date 2021-01-20
Shortage status Resolved
Updated date 2021-01-21
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-12-22 English Compare
v2 2020-12-22 French Compare
v3 2020-12-22 English Compare
v4 2020-12-22 French Compare
v5 2021-01-20 English Compare
v6 2021-01-20 French Compare
v7 2021-01-21 English Compare